|
|
Volumn 1 Suppl 1, Issue , 2000, Pages
|
|
The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGF-receptor kinase inhibitors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR 1;
HUMAN;
METASTASIS;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
ANGIOGENESIS INHIBITORS;
HUMANS;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;
MLCS;
MLOWN;
|
|
EID: 0002957530
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.3816/cbc.2000.s.015 Document Type: Review |
|
Times cited : (81)
|
|
References (42)
|
